This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Curebio Therapeutics, Jw Bioscience. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 3 Years Active: 2026
Title: Jieun Park: Antibody Research and Patent Innovation.
Introduction
Jieun Park is an inventor based in Chungcheongbuk-do, South Korea. Her patent activity includes work on an antibody that specifically binds to WRS protein and its potential uses.
Latest Patents
Park is associated with one patent: “ANTIBODY SPECIFICALLY BINDING TO WRS PROTEIN, AND USE THEREOF.” The invention concerns an antibody targeting WRS protein and its applications. Her record lists 1 patent.
Career Highlights
Park has worked with JW Bioscience and Curebio Therapeutics. Her patent reflects research focused on antibody-based technology.
Collaborations
Park’s listed coworkers include Sumi Bae and Sunghwa Son. These names indicate professional connections associated with her work.
Conclusion
Jieun Park’s patent activity centers on an antibody targeting WRS protein, alongside professional experience connected with JW Bioscience and Curebio Therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile